5791201
Last Update Posted: 2024-12-06
Recruiting
All Genders accepted | 18 Years-65 Years |
17 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 Diabetes
The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D).
Eligibility
Relevant conditions:
Type 1 Diabetes
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Contact Information
Overall Contact
Data sourced from ClinicalTrials.gov